Christopher Austin, CEO of Vesalius Therapeutics & Flagship Pioneering CEO-Partner, previews the year ahead for Vesalius and why focusing on common illness has a such potential for impact. More from Flagship @ JPM2023 here.
Related Companies
- Vesalius Therapeutics Founded: 2019
